Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

MedImmune, Inc.

MedImmune, a wholly-owned subsidiary of Astrazeneca, is a leading innovation-focused biotechnology company focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience biologics.

Search Projects

  • Senior Director, Physiochemical Analysis
  • Senior Director, Protein Purification
  • Senior Director, Translational Medicine
  • Senior Director, Clinical Program Management
  • Senior Director, Clinical Trial Management
  • Senior Director, Product Development Team Leader
  • Senior Director, Vaccine Development
  • Director, Product Development Team Leader
  • Director, Clinical Central Services
  • Senior Director, Research and Development
  • Senior Director, Clinical Informatics
  • Senior Director Clinical Development Oncology
  • Senior Director Epidemiology and Risk Management
  • Medical Director
  • Vice President Autoimmunity and Inflammation
  • Senior Director Clinical Development (CNS)
  • Senior Director Clinical Operations
  • Vice President Biometrics